As prescription drug misuse has risen to epidemic proportions in this country, the focus is centering around semi-synthetic opioids. Because the opiate screen included in the full drug panels detects only codeine, morphine and heroin, ExamOne will offer an expanded opioid panel. Drug overdose deaths and opioid-involved deaths continue to increase in the United States. The Read More »
ExamOne offers expanded opioid panel
ExamOne Expands Services in Canada with Acquisition of Watermark Insurance Services Inc. and BW Underwriting Services Inc.
Transaction to Enhance Integrated Risk Assessment Services for Insurers and Life Insurance Applicants in Canada LENEXA, KAN., June 20, 2017, ExamOne, the leader in helping insurers meet their underwriting needs, has entered into a definitive agreement to acquire Watermark Insurance Services Inc. and BW Underwriting Services Inc., national providers of underwriting services in Canada. Based in Read More »
For nearly five decades, ExamOne has been a leader in providing comprehensive risk analysis services to the life insurance industry. Along the way, we continuously expanded and evolved our core competencies to serve the healthcare industry. Today, we are proud to introduce ExamOne Health Solutions. Leveraging the capabilities which have become our core competencies, we Read More »
— Real-time, health data product takes a personalized approach to risk assessment — Underwriters have new tool to guide smarter decisions and receive instant decision-making results LENEXA, Kansas, February 6, 2017 – ExamOne, a Quest Diagnostics company and leader in helping insurers meet their underwriting needs, announced today the introduction of Risk IdentifierTM. The innovative Read More »
The most recent College of American Pathologist (CAP) checklist¹ contains an updated requirement (COM.40630) for all laboratory-developed tests (LDTs). We must provide the following statement on our laboratory reports: The following tests were developed and their analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. Read More »
Are you looking for ways to speed up the life insurance process? This article, “Technology’s Benefits- shorter turnaround time and improved applicant experience,” written by Vice President of National Sales, John Reynolds, and published in December’s California Broker Magazine identifies several ways technology is helping insurers gain efficiency. Click here for the full article.
As a leader in the life insurance industry, we are committed to ensuring our clients are using the most current and accurate laboratory testing equipment and methodologies. Quest Diagnostics, a leader in diagnostic testing, is passionate about developing innovative, ground-breaking tests, products, and tools to provide value to clients. Earlier this year we announced we would Read More »
September is designated as Life Insurance Awareness Month. This campaign was initiated by Life Happens, a nonprofit organization whose mission is to “inspire the public to take personal financial responsibility through the ownership of life insurance and related products.” According to the 2016 Insurance Barometer study, 40% of Americans still do not have any life Read More »
As a leader in the life insurance industry, we are committed to ensuring our clients are using the most current and most accurate laboratory testing. Quest Diagnostics, a leader in diagnostic testing is passionate about developing innovative, ground-breaking tests, products and tools to provide value to clients, including our recent approval as the first commercial Read More »
Partnership to Offer Special Pricing to Producers for Licensing Exam Preparation and Continuing Education Courses ExamOne, a Quest Diagnostics Company and the nation’s leading provider of risk assessment services to the life insurance industry, is partnering with ExamFX to provide special pricing on licensing exam prep and continuing education to the life insurance industry. ExamFX Read More »